X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
index medicus (22) 22
rheumatoid arthritis (17) 17
article (15) 15
female (14) 14
rheumatology (14) 14
male (13) 13
middle aged (12) 12
aged (11) 11
tumor necrosis factor-alpha - antagonists & inhibitors (11) 11
antirheumatic agents - adverse effects (10) 10
arthritis, rheumatoid - drug therapy (10) 10
risk factors (10) 10
cohort studies (9) 9
risk (8) 8
united states - epidemiology (8) 8
abridged index medicus (7) 7
adult (7) 7
infliximab (7) 7
retrospective studies (7) 7
united states (7) 7
antirheumatic agents - therapeutic use (6) 6
incidence (6) 6
rheumatoid-arthritis (6) 6
safety (6) 6
databases, factual (5) 5
etanercept (5) 5
health aspects (5) 5
research (5) 5
treatment outcome (5) 5
adverse events (4) 4
antibodies, monoclonal - adverse effects (4) 4
arthritis, rheumatoid - complications (4) 4
autoimmune diseases - drug therapy (4) 4
bacterial infections (4) 4
biological products - therapeutic use (4) 4
drug therapy (4) 4
immunocompromised host (4) 4
immunosuppressive agents - adverse effects (4) 4
infection (4) 4
inflammatory bowel disease (4) 4
management (4) 4
psoriasis (4) 4
serious bacterial-infections (4) 4
adalimumab (3) 3
administrative claims data (3) 3
adolescent (3) 3
aged, 80 and over (3) 3
algorithms (3) 3
ankylosing spondylitis (3) 3
arthritis, juvenile - drug therapy (3) 3
arthritis, rheumatoid - epidemiology (3) 3
arthritis, rheumatoid - immunology (3) 3
association (3) 3
autoimmune diseases (3) 3
bacterial infections - epidemiology (3) 3
care and treatment (3) 3
databases (3) 3
diagnosis (3) 3
epidemiology (3) 3
hospitalization - statistics & numerical data (3) 3
immunoglobulin g - adverse effects (3) 3
immunologic factors - adverse effects (3) 3
internal medicine (3) 3
medicaid (3) 3
methotrexate (3) 3
modifying antirheumatic drugs (3) 3
monoclonal-antibody (3) 3
opportunistic infections (3) 3
opportunistic infections - epidemiology (3) 3
osteoporosis (3) 3
pharmacology & pharmacy (3) 3
practice guidelines as topic - standards (3) 3
public, environmental & occupational health (3) 3
shingles (3) 3
time factors (3) 3
tnf inhibitors (3) 3
tuberculosis (3) 3
tumor necrosis factor-alpha (3) 3
acute myocardial-infarction (2) 2
alpha monoclonal-antibody (2) 2
antitumor necrosis factor (2) 2
arthritis, juvenile - diagnosis (2) 2
arthritis, juvenile - epidemiology (2) 2
attention deficit disorder (2) 2
autoimmune diseases - epidemiology (2) 2
autoimmune diseases - immunology (2) 2
bias (2) 2
biologic therapy (2) 2
biological products - adverse effects (2) 2
biologics (2) 2
blastomycosis (2) 2
bone density (2) 2
british-society (2) 2
child (2) 2
coccidioidomycosis (2) 2
codes (2) 2
comorbidity (2) 2
complications and side effects (2) 2
criteria (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Epidemiology, ISSN 0895-4356, 05/2011, Volume 64, Issue 5, p. 573
Journal Article
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 9/2011, Volume 17, Issue 9, pp. 1664 - 1669
TOC summary: Incidence was highest for histoplasmosis and blastomycosis in the Midwest and for coccidioidomycosis in the West. To investigate the epidemiology... 
geographic distribution | endemic mycoses | blastomycosis | dispatch | fungi | United States | coccidioidomycosis | Research | histoplasmosis | rheumatoid arthritis
Journal Article
Journal of Clinical Epidemiology, ISSN 0895-4356, 2011, Volume 64, Issue 1, pp. 46 - 53
Journal Article
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 09/2011, Volume 17, Issue 9, pp. 1664 - 1669
To investigate the epidemiology and geographic distribution of histoplasmosis, coccidioidomycosis, and blastomycosis in older persons in the United States, we... 
ELDERLY PERSONS | HISTOPLASMOSIS | ARIZONA | INFECTIOUS DISEASES | USA | COCCIDIOIDOMYCOSIS | BLASTOMYCOSIS | SURVEILLANCE | SENSITIVITY | OPPORTUNISTIC INFECTIONS | HOSPITALIZATIONS | IMMUNOLOGY | Mycoses | Aged | Research | Diagnosis | Health aspects | Epidemiology | Risk factors | endemic mycoses | coccidioidomycosis | blastomycosis | histoplasmosis | fungi | rheumatoid arthritis
Journal Article
Arthritis Care & Research, ISSN 2151-464X, 01/2012, Volume 64, Issue 1, pp. 157 - 158
Journal Article
Arthritis Care & Research, ISSN 2151-464X, 01/2012, Volume 64, Issue 1, pp. 157 - 158
Journal Article
Journal Article
Arthritis Care & Research, ISSN 2151-464X, 09/2011, Volume 63, Issue 9, pp. 1355 - 1356
Journal Article
Arthritis Care & Research, ISSN 2151-464X, 09/2011, Volume 63, Issue 9, pp. 1355 - 1356
Journal Article
Journal of Clinical Epidemiology, ISSN 0895-4356, 2011, Volume 64, Issue 5, pp. 573 - 573
Journal Article
JAMA: Journal of the American Medical Association, ISSN 0098-7484, 12/2011, Volume 306, Issue 21, pp. 2331 - 2339
Context Although tumor necrosis factor (TNF)- alpha antagonists are increasingly used in place of nonbiologic comparator medications, their safety profile... 
Ankylosing spondylitis
Journal Article
JAMA, The Journal of the American Medical Association, ISSN 0098-7484, 12/2011, Volume 306, Issue 21, p. 2331
A study was conducted to evaluate and compare whether initiation of tumor necrosis factor (TNF)-alpha antagonists as against nonbiologic comparators is... 
Antagonists (Biochemistry) | Drugs | Tumor necrosis factor | Hospital care | Dosage and administration | Product/Service Evaluations | Management | Autoimmune diseases | Drug therapy | Health aspects
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2014, Volume 73, Issue 11, pp. 1942 - 1948
Objectives To determine among patients with autoimmune diseases in the USA whether the risk of non-viral opportunistic infections (OI) was increased among new... 
DMARDs (biologic) | Infections | Tuberculosis | Rheumatoid Arthritis | TNF-alpha | RHEUMATOID-ARTHRITIS | PNEUMOCYSTIS PNEUMONIA | RISK-FACTORS | SERIOUS BACTERIAL-INFECTIONS | FACTOR-ALPHA ANTAGONISTS | GRANULOMATOUS INFECTIONS | BRITISH-SOCIETY | RHEUMATOLOGY | INFLIXIMAB | ANTIBODY THERAPY | MYCOBACTERIAL DISEASES | United States - epidemiology | Biological Therapy - methods | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Opportunistic Infections - chemically induced | Arthritis, Rheumatoid - drug therapy | Antirheumatic Agents - adverse effects | Adult | Biological Products - adverse effects | Female | Opportunistic Infections - immunology | Retrospective Studies | Autoimmune Diseases - drug therapy | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Autoimmune Diseases - epidemiology | Opportunistic Infections - epidemiology | Arthritis, Rheumatoid - epidemiology | Autoimmune Diseases - immunology | Biological Therapy - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Immunocompromised Host | Arthritis, Rheumatoid - immunology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Complications and side effects | Care and treatment | Opportunistic infections | Tumor necrosis factor inhibitors | Dosage and administration | Autoimmune diseases | Risk factors | Codes | Bacterial infections | Medicare | Lung diseases | Inflammatory bowel disease | Immunotherapy | Pharmacy | Gangrene | Tumor necrosis factor-TNF | Medicaid | Viral infections | Pharmaceuticals
Journal Article